Recent advancements in specialized medical therapies, diagnostics, and healthcare system challenges define today's clinical landscape.

The FDA has approved Apitegromab as the first muscle-targeted therapy for patients aged 2 years and older living with spinal muscular atrophy.

Research indicates that replacing preventive cranial radiotherapy with regular MRI surveillance for small-cell lung cancer patients may lead to better clinical outcomes.

Internal reports highlight significant operational challenges in a Medicare AI prior authorization pilot, including provider delays and high rates of non-affirmation.

A study on COPD severity scoring found no inherent racial differences, suggesting that observed disparities are likely driven by social determinants of health.

The CDC issued a warning regarding the overuse of rabies postexposure prophylaxis, urging providers to improve their understanding of appropriate administration criteria.

New findings reveal that survivors of bacterial meningitis face a slightly elevated long-term mortality risk, potentially influenced by shared familial or genetic factors.

JAK inhibitors have demonstrated efficacy in reducing rheumatoid arthritis disease activity across diverse patient demographics, including those with cardiometabolic comorbidities.

A new AI-based algorithm shows strong potential in assessing pathologic responses to neoadjuvant chemoimmunotherapy in patients with non-small-cell lung cancer.